Loading [MathJax]/jax/output/SVG/jax.js
Review

Carbapenem resistance in Enterobacterales from agricultural, environmental and clinical origins: South Africa in a global context

  • Carbapenem agents are regarded as last-resort antibiotics, however, bacterial resistance towards carbapenems has been reported in both clinical and agricultural settings worldwide. Carbapenem resistance, defined as the resistance of a bacteria towards one or more carbapenem drugs, can be mediated in either of, or a combination of, three mechanisms–although, the mechanism mediated through the production of carbapenemases (β-lactamases that are able to enzymatically degrade carbapenems) is of most significance. Of particular concern is the occurrence of carbapenemase producing Enterobacterales (CPE), with literature describing a dramatic increase in resistance globally. In South Africa, increases of carbapenemase activity occurring in Enterobacter species, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa have recently been reported. CPE can also be found in agricultural environments, as global studies have documented numerous instances of CPE presence in various animals such as pigs, cattle, seafood, horses and dogs. However, most reports of CPE occurrence in agricultural settings come from Northern America, Europe and some parts of Asia, where more extensive research has been conducted to understand the CPE phenomenon. In comparison to clinical data, there are limited studies investigating the spread of CPE in agricultural settings in Africa, highlighting the importance of monitoring CPE in livestock environments and the food chain. Further research is necessary to uncover the true extent of CPE dissemination in South Africa. This review will discuss the phenomenon of bacterial antibiotic resistance (ABR), the applications of the carbapenem drug and the occurrence of carbapenem resistance globally.

    Citation: Taish Ramkisson, Diane Rip. Carbapenem resistance in Enterobacterales from agricultural, environmental and clinical origins: South Africa in a global context[J]. AIMS Microbiology, 2023, 9(4): 668-691. doi: 10.3934/microbiol.2023034

    Related Papers:

    [1] Jichun Li, Gaihui Guo, Hailong Yuan . Nonlocal delay gives rise to vegetation patterns in a vegetation-sand model. Mathematical Biosciences and Engineering, 2024, 21(3): 4521-4553. doi: 10.3934/mbe.2024200
    [2] Yuhong Huo, Gourav Mandal, Lakshmi Narayan Guin, Santabrata Chakravarty, Renji Han . Allee effect-driven complexity in a spatiotemporal predator-prey system with fear factor. Mathematical Biosciences and Engineering, 2023, 20(10): 18820-18860. doi: 10.3934/mbe.2023834
    [3] Shuangte Wang, Hengguo Yu . Stability and bifurcation analysis of the Bazykin's predator-prey ecosystem with Holling type Ⅱ functional response. Mathematical Biosciences and Engineering, 2021, 18(6): 7877-7918. doi: 10.3934/mbe.2021391
    [4] Yue Xing, Weihua Jiang, Xun Cao . Multi-stable and spatiotemporal staggered patterns in a predator-prey model with predator-taxis and delay. Mathematical Biosciences and Engineering, 2023, 20(10): 18413-18444. doi: 10.3934/mbe.2023818
    [5] Mingzhu Qu, Chunrui Zhang, Xingjian Wang . Analysis of dynamic properties on forest restoration-population pressure model. Mathematical Biosciences and Engineering, 2020, 17(4): 3567-3581. doi: 10.3934/mbe.2020201
    [6] Rina Su, Chunrui Zhang . The generation mechanism of Turing-pattern in a Tree-grass competition model with cross diffusion and time delay. Mathematical Biosciences and Engineering, 2022, 19(12): 12073-12103. doi: 10.3934/mbe.2022562
    [7] Sourav Kumar Sasmal, Jeet Banerjee, Yasuhiro Takeuchi . Dynamics and spatio-temporal patterns in a prey–predator system with aposematic prey. Mathematical Biosciences and Engineering, 2019, 16(5): 3864-3884. doi: 10.3934/mbe.2019191
    [8] Sangeeta Kumari, Sidharth Menon, Abhirami K . Dynamical system of quokka population depicting Fennecaphobia by Vulpes vulpes. Mathematical Biosciences and Engineering, 2025, 22(6): 1342-1363. doi: 10.3934/mbe.2025050
    [9] Hongyong Zhao, Qianjin Zhang, Linhe Zhu . The spatial dynamics of a zebrafish model with cross-diffusions. Mathematical Biosciences and Engineering, 2017, 14(4): 1035-1054. doi: 10.3934/mbe.2017054
    [10] Martin Baurmann, Wolfgang Ebenhöh, Ulrike Feudel . Turing instabilities and pattern formation in a benthic nutrient-microorganism system. Mathematical Biosciences and Engineering, 2004, 1(1): 111-130. doi: 10.3934/mbe.2004.1.111
  • Carbapenem agents are regarded as last-resort antibiotics, however, bacterial resistance towards carbapenems has been reported in both clinical and agricultural settings worldwide. Carbapenem resistance, defined as the resistance of a bacteria towards one or more carbapenem drugs, can be mediated in either of, or a combination of, three mechanisms–although, the mechanism mediated through the production of carbapenemases (β-lactamases that are able to enzymatically degrade carbapenems) is of most significance. Of particular concern is the occurrence of carbapenemase producing Enterobacterales (CPE), with literature describing a dramatic increase in resistance globally. In South Africa, increases of carbapenemase activity occurring in Enterobacter species, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa have recently been reported. CPE can also be found in agricultural environments, as global studies have documented numerous instances of CPE presence in various animals such as pigs, cattle, seafood, horses and dogs. However, most reports of CPE occurrence in agricultural settings come from Northern America, Europe and some parts of Asia, where more extensive research has been conducted to understand the CPE phenomenon. In comparison to clinical data, there are limited studies investigating the spread of CPE in agricultural settings in Africa, highlighting the importance of monitoring CPE in livestock environments and the food chain. Further research is necessary to uncover the true extent of CPE dissemination in South Africa. This review will discuss the phenomenon of bacterial antibiotic resistance (ABR), the applications of the carbapenem drug and the occurrence of carbapenem resistance globally.



    Antibiotics are the secondary metabolites of certain microorganisms that can selectively inhibit or kill other microorganisms at low concentrations without bringing serious toxicity to the host. Under the action of antibiotics, a large number of sensitive bacteria are inhibited or killed, but a few sensitive bacteria change their metabolic pathways and become resistant bacteria. Repeated application of the same antibiotics results in a screening of resistant bacteria and antibiotics are ineffective once resistant bacteria become dominant, which aggravates the hazard of bacterial infection to human health [1]. Therefore, many scholars have invested their energy in studying bacterial resistance [2,3,4,5,6,7,8,9,10]. In Reference [2], Austin and Anderson formulated a model to describe the transmission dynamics of resistant bacteria between the host and the medical staff. Their study aimed to reveal the necessity of strengthening clinical management of patients infected with bacteria. In Reference [3], Blair and Webber expounded the molecular mechanisms of bacterial resistance including intrinsic resistance and acquired resistance. In Reference [6], authors assumed that bacterial resistance is acquired by genetic mutation and plasmid transfer and formulated a population dynamic model of sensitive and resistant bacteria to antibiotics. The stability of the coexistence equilibrium and the existence of the limit cycle is discussed. In Reference [10], the author formulated the following model to investigate the dynamic changes of bacterial resistance in a single bacterial population that is exposed to a single antibiotic:

    {dxdt=(αβ(x+y))xγηx+δy,dydt=(αβ(x+y))yδy, (1.1)

    where x(t) and y(t) are two distinct populations of the same species of disease-causing bacteria. x(t) denotes the density of sensitive bacteria in the bacterial population and y(t) denotes the density of resistant bacteria in the bacterial population. α is the growth rate of the two kinds of bacteria. In view of limited nutrients in the host, struggle for survival between the two kinds of bacteria will cause them to be sifted out at a rate of β. γ is the antimicrobial ability, which is larger for bactericidal antibiotics compared to bacteriostatic antibiotics. η is the antibiotic concentration. δ is the conversion rate of resistant bacteria losing resistance and converting into sensitive bacteria. All the above parameters are positive constants. By qualitative analysis, Garber gave the conditions under which resistant bacteria will go to extinction.

    How to optimize the antibiotic treatment measures is a topic that mathematicians have been interested in for a long time [11,12,13,14,15,16,17,18]. In Reference [11], authors introduced the impulsive state feedback control into the system (1.1) and then got the following system:

    {dxdt=(αβ(x+y))xγηx+δydydt=(αβ(x+y))yδy}y<h,Δx=x(t+)x(t)=θhΔy=y(t+)y(t)=θh}y=h. (1.2)

    The orbital stability of the order-1 periodic solution is presented. It can be seen that the density of resistant bacteria is limited to a lower level in the system with impulsive state feedback control. In Reference [14], the authors formulated a model to simulate the contribution of antibiotics and immune system to combat bacterial infection and then propounded an optimal control problem. The optimal control is found by applying Pontryagins Maximum Principle. In reference [17], the authors mainly focused on the two subpopulations of the same species. One subpopulation has an intrinsic resistance to drugs and the other one is sensitive to drugs. The authors formulated a nonlinear objective function to achieve the following two goals: (i) minimize the size of the bacterial population, (ii) prevent resistant bacteria from becoming dominant. The results indicate that the optimal control contains a singular interval.

    Currently, impulsive state feedback control has been widely applied in various fields such as biology, medicine, etc. [19,20,21,22]. Meanwhile, the study of the periodic solution has made many new advances [23,24,25,26,27,28,29,30]. In Reference [19], authors established a crop pest management model with impulsive state feedback control. It can be known that observations and records of the pest quantity at different stages of crops can help to control the size of the pest population. In Reference [25], authors reviewed the research results of the periodic solution since 2010 and presented the recent research results.

    This paper is organized as follows: In Section 2, we formulate a model of conversion between sensitive and resistant bacteria and then introduce impulsive state feedback control to optimize antibiotic treatment measures. In Section 3, the global asymptotic stability of the positive equilibrium is discussed. In Section 4, the orbital stability of the order-1 periodic solution is proved. In Section 5, the numerical simulation is used to confirm our results.

    Motivated by [10], the conversion rate of resistant bacteria losing resistance and converting into sensitive bacteria is represented by δyk+y. We can obtain limy+δyk+y=δ, which shows that as the density of resistant bacteria increases, the conversion rate of resistant bacteria losing resistance and converting into sensitive bacteria increases and gradually tends towards δ. We give the following system:

    {dxdt=(αβ(x+y))xγηx+δyk+y,dydt=(αβ(x+y))yδyk+y, (2.1)

    where x(t) and y(t) are two distinct populations of the same species of disease-causing bacteria. x(t) denotes the density of sensitive bacteria in the bacterial population and y(t) denotes the density of resistant bacteria in the bacterial population. α is the growth rate of the two kinds of bacteria. In view of limited nutrients in the host, struggle for survival between the two kinds of bacteria will cause them to be sifted out at a rate of β. γ is the antimicrobial ability, which is larger for bactericidal antibiotics compared to bacteriostatic antibiotics. η is the antibiotic concentration. All the above parameters are positive constants.

    Severe bacterial infection can endanger life. Clinically, antibiotics are commonly used to inhibit or kill disease-causing bacteria. However, prolonged administration of the same antibiotics can cause bacterial resistance, which, in turn, makes the antibiotic effect worse and even disappear. We can use other antibiotics when one antibiotic loses its effectiveness, but bacteria still become resistant to new antibiotics after long-term use. Thus, replacing antibiotics doesn't fundamentally reduce bacterial resistance. We need to optimize the antibiotic treatment measures to extend or restore the antibiotic effectiveness. Inspired by [11,12], we introduce the impulsive state feedback control into the system (2.1) and then get the following system:

    {dxdt=(αβ(x+y))xγηx+δyk+ydydt=(αβ(x+y))yδyk+y}y<h,Δx=x(t+)x(t)=θhΔy=y(t+)y(t)=θh}y=h. (2.2)

    where h is the critical threshold value of resistant bacteria at which antibiotics lose best treatment for patients. When the density of resistant bacteria reaches the critical threshold value h, θ multiples of resistant bacteria become sensitive bacteria under the impulsive effect (0<θ<1).

    For convenience, we give the following definitions and theorems.

    Definition 2.1 [25] Consider a two dimensional state dependent impulsive differential equation

    {dxdt=P(x,y)dydt=Q(x,y)}(x,y)M(x,y),Δx=μ(x,y)Δy=v(x,y)}(x,y)=M(x,y). (2.3)

    Suppose the impulsive set M and phase set N of system (2.3) fall between two parallel lines, the intersection of y-axis with the phase set N line is F. Due to the pulse effect, any trajectory starting from N reaches the impulsive set M and then is mapped to IN. Then the point I is called the successor point of the point G and g(G)=|FI||FG| is called the successor function of the point G, where |FI|, |FG| are the distance between the point F and the point I and between the point F and the point G, respectively.

    Theorem 2.1 [25] The successor function g is continuous.

    Theorem 2.2 [25] Assume ^n1n2¯n1n2 is an order-1 cycle and the point m is the successor point of e. According to the position between the points n1, e and m, the order-1 periodic solution is classified into three types:

    1) Type 1: the order-1 cycle ^n1n2¯n1n2 is convex, and the points e and m are at the same side of n1 as shown in Figure 1(a).

    Figure 1.  Three types of the order-1 periodic solution.

    2) Type 2: the order-1 cycle ^n1n2¯n1n2 is not convex, yet the points e and m are at the same side of n1 as shown in Figure 1(b).

    3) Type 3: the points e and m are at different sides of n1 as shown in Figure 1(c).

    Theorem 2.3 [25] If Γ is a type 1 order-1 periodic solution with period T and the integral along Γ satisfies

    T0(Px+Qy)dt<0,

    Γ is orbital stable.

    Theorem 2.4 [25] If Γ is a type 1 order-1 periodic solution and the region that contains Γ satisfies

    Px+Qy<0,

    Γ is orbital stable.

    Without the impulsive effect, the system (2.2) is reduced to

    {dxdt=(αβ(x+y))xγηx+δyk+yP(x,y),dydt=(αβ(x+y))yδyk+yQ(x,y). (3.1)

    Theorem 3.1. The system (3.1) is uniformly bounded in the first quadrant.

    Proof. The positive x-axis is either a single trajectory or a combination of an equilibrium point and two trajectories. However, both cases imply that no trajectory intersects with the positive x-axis.

    Obviously, dxdt|x=0=δyk+y>0 holds for y>0, which shows that when meeting the positive y-axis, the trajectory will pass through it from left to right (see Figure 2).

    Figure 2.  Boundedness.

    By investigating the straight line lx+yαβ=0, we can obtain

    dldt|l=0=[(αβ(x+y))(x+y)γηx]|l=0=γηx<0

    for x>0, which indicates that when meeting the straight line l=0 in the first quadrant, the trajectory will pass through it from upper right to lower left (see Figure 2).

    From the above, we can see that the system (3.1) is uniformly bounded in the first quadrant.

    The proof is completed.

    The equilibria of the system (3.1) are given by

    {(αβ(x+y))xγηx+δyk+y=0,(αβ(x+y))yδyk+y=0. (3.2)

    From the second equation of (3.2), we can obtain y=0 or x=αβδβ(k+y)y. By substituting y=0 in the first equation of (3.2), we can obtain x=0 or x=αγηβ, so the equilibrium E0(0,0) always exists and the equilibrium E1(αγηβ,0) exists if α>γη holds.

    By substituting x=αβδβ(k+y)y in the first equation of (3.2), we can obtain

    Φ(y)=ay3+by2+cy+d=0, (3.3)

    where

    a=βγη,b=2βγηkαγη,c=αδ+γηδ+βγηk22αγηk,d=(αkδ)(δγηk).

    Theorem 3.2. If βk2>αk>δ and γηk>δ hold, the system (3.1) has a unique positive equilibrium.

    Proof. Suppose y1,y2,y3 are three roots of Φ(y)=0 defined in (3.3) in the complex number field. According to the Vieta theorem, we can obtain

    {y1y2y3=da=(αkδ)(γηkδ)βγη,y1+y2+y3=ba=α2βkβ.

    If βk2>αk>δ and γηk>δ hold, we can obtain

    {y1y2y3>0,y1+y2+y3<0.

    Thus, Φ(y)=0 defined in (3.3) has one positive real root and two complex roots with negative real parts. Hence, Φ(y)=0 defined in (3.3) has a unique positive real root. Consequently, the system (3.1) has a unique positive equilibrium.

    The proof is completed.

    The Jacobian matrix of the system (3.1) is

    J(E(x,y))=[αβ(x+y)βxγηβx+δk(k+y)2βyαβ(x+y)βyδk(k+y)2].

    Theorem 3.3. If min{γη,δk}>α holds, the equilibrium E0(0,0) is a stable node. If max{γη,δk}>α>min{γη,δk} holds, the equilibrium E0(0,0) is a saddle point. If α>max{γη,δk} holds, then the equilibrium E0(0,0) is an unstable node.

    Proof. The Jacobian matrix at the equilibrium E0(0,0) is

    J(E0(0,0))=[αγηδk0αδk].

    The eigenvalues of J(E0(0,0)) are

    λ1=αγη,
    λ2=αδk.

    If min{γη,δk}>α holds, we can obtain λ1<0, λ2<0. Thus, the equilibrium E0(0,0) is a stable node. If max{γη,δk}>α>min{γη,δk} holds, we can obtain λ1>0, λ2<0 or λ1<0, λ2>0. Hence, the equilibrium E0(0,0) is a saddle point. If α>max{γη,δk} holds, we can obtain λ1>0, λ2>0. Therefore, the equilibrium E0(0,0) is an unstable node.

    The proof is completed.

    Theorem 3.4. If min{α,δk}>γη holds, the equilibrium E1(αγηβ,0) is a stable node. If α>γη>δk holds, the equilibrium E1(αγηβ,0) is a saddle point.

    Proof. The Jacobian matrix at the equilibrium E1(αγηβ,0) is

    J(E1(αγηβ,0))=[γηαγηα+δk0γηδk].

    The eigenvalues of J(E1(αγηβ,0)) are

    λ1=γηα,
    λ2=γηδk.

    If min{α,δk}>γη holds, we can obtain λ1<0, λ2<0. Hence, the equilibrium E1(αγηβ,0) is a stable node. If α>γη>δk holds, we can obtain λ1<0, λ2>0. Therefore, the equilibrium E1(αγηβ,0) is a saddle point.

    The proof is completed.

    Theorem 3.5. If βk2>αk>δ and γηk>δ hold, the unique positive equilibrium E(x,y) is globally asymptotically stable.

    Proof. The Jacobian matrix at the positive equilibrium E(x,y) is

    J(E(x,y))=[αβ(x+y)βxγηβx+δk(k+y)2βyαβ(x+y)βyδk(k+y)2].

    Combined with x=αβδβ(k+y)y, we can obtain

    J(E(x,y))=[2δk+y+βyαγηδk+y+βyα+δk(k+y)2βyδk+yβyδk(k+y)2].

    If βk2>αk>δ and γηk>δ hold, we can obtain

    tr(J(E(x,y)))=(2δk+y+βyαγη)+(δk+yβyδk(k+y)2)=3δk+yδk(k+y)2αγη=(α+γη)(y)2+(2αk+2γηk3δ)y+k(αk+γηk2δ)(k+y)2<0,

    and

    det(J(E(x,y)))=|2δk+y+βyαγηδk+y+βyα+δk(k+y)2βyδk+yβyδk(k+y)2|=αδk+γηδk+2δ2(k+y)2+βγηyαδ+γηδk+y2δ2k(k+y)3=βγη(y)4+3βγηk(y)3+(3βγηk2αδγηδ)(y)2+(βγηk3αδkγηδk+2δ2)y(k+y)3>βγη(y)4+3βγηk(y)3+(3αγηkαδγηδ)(y)2+(αγηk2αδkγηδk+2δ2)y(k+y)3=βγη(y)4+3βγηk(y)3+(αγηk+α(γηkδ)+γη(αkδ))(y)2(k+y)3+((αkδ)(γηkδ)+δ2)y(k+y)3>0.

    Therefore, the unique positive equilibrium E(x,y) is locally asymptotically stable.

    Define a Dulac function D(x,y)=1xy and we can obtain

    (D(x,y)P(x,y))x+(D(x,y)Q(x,y))y=βyδ(k+y)x2βx+δ(k+y)2x=βyδ(k+y)x2βy2+2βky+βk2δ(k+y)2x<0,

    which implies that there is no limit cycle in the first quadrant. Consequently, the unique positive equilibrium E(x,y) is globally asymptotically stable.

    The proof is completed.

    Theorem 4.1. When h<y, the system (2.2) has a unique order-1 periodic solution.

    Proof. From the system (2.2), we can obtain the impulsive set M={(x,y)R2+|x0,y=h} and the phase set N={(x,y)R2+|xθh,y=(1θ)h}. When h<y, both the impulsive set M and the phase set N are below the positive equilibrium E(x,y).

    Now, we will prove the existence of the order-1 periodic solution. Suppose the straight line y=(1θ)h intersects with isoclines dxdt=0 and dydt=0 at points R and S, respectively (see Figure 3(a)). The trajectory initiating from the point R(xR,(1θ)h) intersects with the impulsive set M at the point RM and then the point RM is mapped to RN(xRN,(1θ)h) due to the impulsive effect. The point RN is the successor point of the point R. The point RN must be on the right of the point R according to the property of the vector field, and therefore the successor function satisfies

    g(R)=xRNxR>0.

    Similarly, the trajectory initiating from the point S(xS,(1θ)h) reaches the impulsive set M at the point SM and then the point SM jumps to SN(xSN,(1θ)h) due to the impulsive effect. The point SN is the successor point of the point S. The point SN must be on the left of the point S according to the property of the vector field, and hence the successor function satisfies

    g(S)=xSNxS<0.

    Following the continuity of the successor function, there must be a point W between R and S that makes g(W)=0 hold. The trajectory initiating from the point W hits the impulsive set M at the point WM and then the point WM is mapped back to W itself due to the impulsive effect. In consequence, the system (2.2) has an order-1 periodic solution.

    Figure 3.  (a) Existence of the order-1 periodic solution. (b) Uniqueness of the order-1 periodic solution.

    Next, we will prove the uniqueness of the order-1 periodic solution. We arbitrarily choose two points T and U in the phase set N where xT<xU (see Figure 3(b)). The trajectory initiating from the point T reaches the impulsive set M at the point TM and then the point TM jumps to TN due to the impulsive effect. The point TN is the successor point of the point T. Similarly, the trajectory initiating from the point U intersects with the impulsive set M at the point UM and then the point UM is mapped to UN due to the impulsive effect. The point UN is the successor point of the point U. Since xUxT>xUMxTM and xUMxTM=xUNxTN hold, we can obtain xUxT>xUNxTN. Hence the successor function satisfies

    g(U)g(T)=(xUNxU)(xTNxT)=(xUNxTN)(xUxT)<0.

    Hence, the successor function g is monotonically decreasing in the phase set N. Therefore, there must be only one point W that makes g(W)=0 hold. In consequence, the system (2.2) has a unique order-1 periodic solution.

    The proof is completed.

    Theorem 4.2. When h<y, the unique order-1 periodic solution of the system (2.2) is orbital stable.

    Proof. From Figure 3(a) and Theorem 2.2, we can conclude that the order-1 periodic solution of the system (2.2) is a type 1 order-1 periodic solution. Define a Dulac function D(x,y)=1xy and the stability of the order-1 periodic solution of the system (2.2) can be decided by the system:

    {d¯xdt=D(x,y)dxdt=αβ(x+y)yγηy+δx(k+y)=D(x,y)P(x,y),d¯ydt=D(x,y)dydt=αβ(x+y)xδx(k+y)=D(x,y)Q(x,y).

    We can obtain

    (D(x,y)P(x,y))x+(D(x,y)Q(x,y))y=βyδ(k+y)x2βx+δ(k+y)2x=βyδ(k+y)x2βy2+2βky+βk2δ(k+y)2x<0.

    According to Theorem 2.4, we can know that the unique order-1 periodic solution of the system (2.2) is orbital stable.

    The proof is completed.

    Let parameters α=2, β=0.8, γ=0.3, η=0.9, δ=1, k=4 and parameters α=2, β=0.8, γ=0.3, η=3, δ=1, k=4. Both cases satisfy the conditions of Theorem 3.5, and therefore the unique positive equilibrium E(x,y) is globally asymptotically stable in both cases. The numerical simulation is used to confirm the result (see Figures 4 and 5). We get the positive equilibrium E(x,y)=(1.898,0.312) for η=0.9, which is simulated in Figure 4. With the increase in the antibiotic concentration, we get the positive equilibrium E(x,y)=(0.434,1.852) for η=3, which is simulated in Figure 5. It can be seen that the density of resistant bacteria increases as the antibiotic concentration increases. This means that prolonged administration of the same antibiotics can cause bacterial resistance, which, in turn, makes the antibiotic effect worse and even disappear.

    Figure 4.  Time series and phase portrait of system (3.1) with parameters α=2, β=0.8, γ=0.3, η=0.9, δ=1, k=4, E(x,y)=(1.898,0.312).
    Figure 5.  Time series and phase portrait of system (3.1) with parameters α=2, β=0.8, γ=0.3, η=3, δ=1, k=4, E(x,y)=(0.434,1.852).

    Antibiotics play a vital role in the fight between humans and disease-causing bacteria, so we need to optimize the antibiotic treatment measures to extend or restore the antibiotic effectiveness. In this paper, we formulate a simplified model of conversion between sensitive and resistant bacteria with the impulsive state feedback control. Let parameters α=2, β=0.8, γ=0.3, η=3, δ=1, k=4, h=0.4, θ=0.9. This case satisfies the conditions of Theorem 3.5 and Theorem 4.1, and therefore the unique order-1 periodic solution of the system (2.2) is orbital stable in this case. The numerical simulation is used to confirm the result (see Figure 6). It can be seen that there is an oscillation of the density of resistant bacteria in an interval below the critical threshold value when the impulsive state feedback control is adopted. This strongly shows that the impulsive state feedback control can reduce bacterial resistance.

    Figure 6.  Time series and phase portrait of system (2.2) with parameters α=2, β=0.8, γ=0.3, η=3, δ=1, k=4, h=0.4, θ=0.9.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.

    This work is supported by the National Natural Science Foundation of China (No.12171193 and 12271346), the project of the Distinguished Professor of colleges and universities of Henan province in 2019 and Project of Foreign expert in Henan (HNGD2023074).

    The authors declare that they have no conflict of interest in the manuscript.



    Conflict of interest



    The authors declare no conflict of interest.

    Author contributions:



    Conceptualization, D.R, Original manuscript preparation, T.R, Review and Editing, D.R and T.R, Project administration, DR.

    [1] Varela AR, Giovanna F, Vredenburg J, et al. (2013) Vancomycin resistant Enterococci: From the hospital effluent to the urban wastewater treatment plant. Sci Total Environ 450: 155-161. https://doi.org/10.1016/j.scitotenv.2013.02.015
    [2] Ampaire L, Muhindo A, Orikiriza P, et al. (2016) A review of antimicrobial resistance in East Africa. Afr J Lab Med 5: 432. https://doi.org/10.4102/ajlm.v5i1.432
    [3] Bai X, Ma X, Xu F, et al. (2015) The drinking water treatment process as a potential source of affecting the bacterial antibiotic resistance. Sci Total Environ 533: 24-32. https://doi.org/10.1016/j.scitotenv.2015.06.082
    [4] Kim J, Ahn J (2022) Emergence and spread of antibiotic resistant foodborne pathogens from farm to table. Food Sci Biotechnol 31: 1481-1499. https://doi.org/10.1007/s10068-022-01157-1
    [5] Wallmann J (2006) Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals. Int J Med Microbiol 296: 81-86. https://doi.org/10.1016/j.ijmm.2006.01.064
    [6] McNulty K, Soon JM, Wallace CA, et al. (2016) Antimicrobial resistance monitoring and surveillance in the meat chain: A report from five countries in the European Union and European economic area. Trends Food Sci Technol 58: 1-13. https://doi.org/10.1016/j.tifs.2016.09.010
    [7] Singh-Moodley A, Ismail H, Perovic O (2018) An overview of antimicrobial resistance surveillance among healthcare-associated pathogens in South Africa. Afr J Lab Med 7: 741. https://doi.org/10.4102/ajlm.v7i2.741
    [8] Threlfall J (2013) New research on antimicrobial resistance in foodborne pathogens. Advances in Microbial Food Safety . United Kingdom: Elsevier 134-156. https://doi.org/10.1533/9780857098740.2.134
    [9] Moellering RCJ, Eliopoulos GM, Sentochnik DE (1989) The carbapenems: New broad spectrum beta-lactam antibiotics. J Antimicrob Chemother 24: 1-7. https://doi.org/10.1093/jac/24.suppl_A.1
    [10] Jackson JJ, Kropp H (1992) Beta-lactam antibiotic-induced release of free endotoxin: In vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. J Infect Dis 165: 1033-1041. https://doi.org/10.1093/infdis/165.6.1033
    [11] Zhanel GG, Wiebe R, Dilay L, et al. (2007) Comparative Review of the Carbapenems. Drugs 67: 1027-1053. https://doi.org/10.2165/00003495-200767070-00006
    [12] Dong LT, Espinoza HV, Espinoza JL (2020) Emerging superbugs: The threat of Carbapenem Resistant Enterobacteriaceae. AIMS Microbiol 6: 176-182. https://doi.org/10.3934/microbiol.2020012
    [13] Das S (2023) The crisis of carbapenemase-mediated carbapenem resistance across the human–animal–environmental interface in India. Infect Dis Now 53: 104628. https://doi.org/10.1016/j.idnow.2022.09.023
    [14] Mollenkopf DF, Stull JW, Mathys DA, et al. (2017) Carbapenemase-producing Enterobacteriaceae recovered from the environment of a swine farrow-to-finish operation in the United States. Antimicrob Agents Chemother 61: e01298-16. https://doi.org/10.1128/AAC.01298-16
    [15] Baughman RP (2009) The use of carbapenems in the treatment of serious infections. J Intensive Care Med 24: 230-241. https://doi.org/10.1177/0885066609335660
    [16] Farley E, Stewart A, Davies M, et al. (2018) Antibiotic use and resistance: Knowledge, attitudes and perceptions among primary care prescribers in South Africa. S Afr Med J 108: 763-771. https://doi.org/10.7196/SAMJ.2018.v108i9.12933
    [17] Queenan AM, Bush K (2007) Carbapenemases: The versatile beta-lactamases. Clin Microbiol Rev 20: 440-458. https://doi.org/10.1128/CMR.00001-07
    [18] Manenzhe RI, Zar HJ, Nicol MP, et al. (2014) The spread of carbapenemase-producing bacteria in Africa: A systematic review. J Antimicrob Chemother 70: 23-41. https://doi.org/10.1093/jac/dku356
    [19] Bonardi S, Pitino R (2019) Carbapenemase-producing bacteria in food-producing animals, wildlife and environment: A challenge for human health. Ital J Food Saf 8: 7956. https://doi.org/10.4081/ijfs.2019.7956
    [20] Vasoo S, Cunningham SA, Kohner PC, et al. (2013) Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP Test, with the Modified Hodge Test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol 51: 3097-3102. https://doi.org/10.1128/JCM.00965-13
    [21] Fischer J, Rodríguez I, Schmoger S, et al. (2013) Salmonella enterica Subsp. Enterica producing VIM-1 carbapenemase isolated from livestock farms. J Antimicrob Chemother 68: 478. https://doi.org/10.1093/jac/dks393
    [22] Sekyere JO (2016) Current state of resistance to antibiotics of last-resort in South Africa: A review from a public health perspective. Front Public Health 4: 209. https://doi.org/10.3389/fpubh.2016.00209
    [23] Köck R, Daniels-Haardt I, Becker K, et al. (2018) Carbapenem-resistant Enterobacteriaceae in wildlife, food-producing, and companion animals: A systematic review. Clin Microbiol Infect 24: 1241-1250. https://doi.org/10.1016/j.cmi.2018.04.004
    [24] Tshitshi L, Manganyi MC, Montso PK, et al. (2020) Extended spectrum beta-lactamase-resistant determinants among carbapenem-resistant Enterobacteriaceae from beef cattle in the North West province, South Africa: A critical assessment of their possible public health implications. Antibiotics 9: 820. https://doi.org/10.3390/antibiotics9110820
    [25] Mollenkopf DF, Cenera JK, Bryant EM, et al. (2014) Organic or antibiotic-free labelling does not impact the recovery of enteric pathogens and antimicrobial resistant Escherichia coli from fresh retail chicken. Foodborne Pathog Dis 11: 920-929. https://doi.org/10.1089/fpd.2014.1808
    [26] CDC.Centers for Disease Control and Prevention: Antibiotic Resistance Threats in the United States. Centers for Disease Control and Prevention, Atlanta, GA (2019) . http://dx.doi.org/10.15620/cdc:82532
    [27] Kempf M, Rolain J, Diatta G, et al. (2012) Carbapenem resistance and Acinetobacter baumannii in Senegal: The paradigm of a common phenomenon in natural reservoirs. PLoS One 7: 1-9. https://doi.org/10.1371/journal.pone.0039495
    [28] Pederson T, Sekyere JO, Govinden U, et al. (2018) Spread of plasmid-encoded NDM-1 and GES-5 carbapenemases among extensively drug-resistant and pandrug-resistant clinical Enterobacteriaceae in Durban, South Africa. Antimicrob Agents Chemother 62: e02178-17. https://doi.org/10.1128/AAC.02178-17
    [29] Ssekatawa K, Byarugaba DK, Wampande E, et al. (2018) Systematic review: The current status of carbapenem resistance in east Africa. BMC Res Notes 11: 629-629. https://doi.org/10.1186/s13104-018-3738-2
    [30] Ekwanzala MD, Dewar JB, Kamika I, et al. (2018) Systematic review in South Africa reveals antibiotic resistance genes shared between clinical and environmental settings. Infect Drug Resist 12: 1907. https://doi.org/10.2147/IDR.S170715
    [31] Van Den Honert MS, Gouws PA, Hoffman LC (2018) Importance and implications of antibiotic resistance development in livestock and wildlife farming in South Africa: A review. S Afr J Animal Sci 48: 1-12. https://doi.org/10.4314/sajas.v48i3.1
    [32] Fritsche TR, Stilwell MG, Jones RN (2003) Antimicrobial activity of doripenem (S-4661): A global surveillance report. Clin Microbiol Infect 11: 974-985. https://doi.org/10.1111/j.1469-0691.2005.01271.x
    [33] (2014) WHOAntimicrobial resistance: global report on surveillance. France: World Health Organization.
    [34] Nys S, Okeke IN, Kariuki S, et al. (2004) Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 54: 952-955. https://doi.org/10.1093/jac/dkh448
    [35] Perovic O, Singh-Moodley A, Duse A, et al. (2015) National sentinel site surveillance for antimicrobial resistance in Klebsiella pneumoniae isolates in South Africa, 2010–2012. S Afr Med J 104: 563-568. https://doi.org/10.7196/SAMJ.7617
    [36] Mwanyika GO, Subbiah M, Buza J, et al. (2017) A systematic review of antibiotic-resistant Escherichia coli and Salmonella data obtained from Tanzanian healthcare settings (2004–2014). Afr J Microbiol Resist 11: 45. https://doi.org/10.5897/AJMR2016.8282
    [37] Baur D, Gladstone BP, Burkert F (2017) Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: A systematic review. Lancet Infect Dis 17: 990-1001. https://doi.org/10.1016/S1473-3099(17)30325-0
    [38] Eager H, Swan G, Van Vuuren M (2012) A survey of antimicrobial usage in animals in South Africa with specific reference to food animals. J S Afr Vet Assoc 83: 1-8. ISSN: 1019-9128
    [39] (2015) WHOGlobal antimicrobial resistance surveillance system: manual for early implementation. Geneva: World Health Organization.
    [40] Mendelson M, Matsoso MP (2015) The South African antimicrobial resistance strategy framework. Antimicrob Resist Control 5: 54-61.
    [41] Brink A, Feldman C, Duse A, et al. (2006) Guideline for the management of nosocomial infections in South Africa. S Afri Med J 93: 642-652. https://doi.org/10.1080/10158782.2006.11441269
    [42] CDC, National Center for Emerging and Zoonotic Infectious Diseases, and Division of Healthcare Quality PromotionCRE Technical Information (2019). Available from: https://www.cdc.gov/hai/organisms/cre/technical-info.html#Definition
    [43] Richmond MH, Sykes RB (1973) The β-lactamases of Gram-negative bacteria and their possible physiological role. Adv Microb Physiol 9: 31-88. https://doi.org/10.1016/S0065-2911(08)60376-8
    [44] Jones RN, Sader HS, Fritsche TR (2005) Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various β-lactamase resistance mechanisms. Diagno Microbiol Infect Dis 52: 71-74. https://doi.org/10.1016/j.diagmicrobio.2004.12.008
    [45] Nordmann P, Poirel L, Toleman MA, et al. (2011) Does broad-spectrum & β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?. J Antimicrob Chemother 66: 689-692. https://doi.org/10.1093/jac/dkq520
    [46] Abdalla SE, Abia ALK, Amoako DG, et al. (2021) From farm-to-fork: E. coli from an intensive pig production system in South Africa shows high resistance to critically important antibiotics for human and animal use. Antibiotics 10: 178. https://doi.org/10.3390/antibiotics10020178
    [47] Nordmann P, Naas T, Poirel L (2011) Global spread of carbapenemase-producing Enterobacteriaceae. Emerging Infect Dis 17: 1791-1798. https://doi.org/10.3201/eid1710.110655
    [48] Papp-Wallace KM, Endimiani A, Taracila MA, et al. (2011) Carbapenems: past, present, and future. Antimicrob Agents Chemother 55: 4943-4960. https://doi.org/10.1128/AAC.00296-11
    [49] Limansky AS, Mussi MA, Viale AM (2002) Loss of a 29-Kilodalton outer membrane protein in Acinetobacter baumannii is associated with imipenem resistance. J Clin Microbiol 40: 4776-4778. https://doi.org/10.1128/JCM.40.12.4776-4778.2002
    [50] Katayama Y, Zhang H, Chambers HF (2004) PBP 2a mutations producing very-high-level resistance to beta-lactams. Antimicrob Agents Chemother 48: 453-459. https://doi.org/10.1128/AAC.48.2.453-459.2004
    [51] Koga T, Sugihara C, Kakuta M, et al. (2009) Affinity of tomopenem (CS-023) for penicillin-binding proteins in Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 1238-1241. https://doi.org/10.1128/AAC.01433-08
    [52] Gehrlein M, Leying H, Cullmann W, et al. (1991) Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins. Chemotherapy 37: 405-412. https://doi.org/10.1159/000238887
    [53] Fernández-Cuenca F, Martínez-Martínez L, Conejo MC, et al. (2003) Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother 51: 565-574. https://doi.org/10.1093/jac/dkg097
    [54] Hancock RE, Brinkman FS (2002) Function of Pseudomonas porins in uptake and efflux. Annual Rev Microbiol 56: 17-38. https://doi.org/10.1146/annurev.micro.56.012302.160310
    [55] Riera E, Cabot G, Mulet X, et al. (2011) Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: Impact on the activity of imipenem, meropenem and doripenem. J Antimicrob Chemother 66: 2022-2027. https://doi.org/10.1093/jac/dkr232
    [56] Pai H, Kim JW, Kim J, et al. (2001) Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 45: 480-484. https://doi.org/10.1128/AAC.45.2.480-484.2001
    [57] Shah PM, Isaacs RD (2003) Ertapenem, the first of a new group of carbapenems. J Antimicrob Chemother 52: 538-542. https://doi.org/10.1093/jac/dkg404
    [58] Walsh TR (2010) Emerging carbapenemases: A global perspective. Int J Antimicrob Agents 36: 8-14. https://doi.org/10.1016/S0924-8579(10)70004-2
    [59] Tamma PD, Simner PJ (2018) Phenotypic detection of carbapenemase-producing organisms from clinical isolates. J Clin Microbiol 56. https://doi.org/10.1128/JCM.01140-18
    [60] Winokur PL, Canton R, Casellas JM, et al. (2001) Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the western Pacific region. Clin Infect Dis 32: 94-103. https://doi.org/10.1086/320182
    [61] Thomson KS, Moland ES (2001) Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 45: 3548. https://doi.org/10.1128/AAC.45.12.3548-3554.2001
    [62] Yigit H, Queenan AM, Anderson GJ, et al. (2001) Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45: 1151-1161. https://doi.org/10.1128/AAC.45.4.1151-1161.2001
    [63] Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39: 1211-1233. https://doi.org/10.1128/AAC.39.6.1211
    [64] Boutal H, Vogel A, Bernabeu S, et al. (2018) A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 73. https://doi.org/10.1093/jac/dkx521
    [65] Miriagou V, Cornaglia G, Edelstein M, et al. (2010) Acquired carbapenemases in Gram-negative bacterial pathogens: Detection and surveillance issues. Clini Microbiol Infect 16: 112-122. https://doi.org/10.1111/j.1469-0691.2009.03116.x
    [66] Kopotsa K, Sekyere JO, Mbelle NM (2019) Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review. Ann N Y Acad Sci 1457: 61-91. https://doi.org/10.1111/nyas.14223
    [67] Rozwandowicz M, Brouwer MSM, Fischer J, et al. (2018) Plasmids carrying antimicrobial resistance genes in Enterobacteriaceae. J Antimicrob Chemother 73: 1121-1137. https://doi.org/10.1093/jac/dkx488
    [68] Mathers AJ, Peirano G, Pitout JDD (2015) The Role of Epidemic Resistance Plasmids and International High-Risk Clones in the Spread of Multidrug-Resistant Enterobacteriaceae. Clin Microbiol Rev 28: 565-591. https://doi.org/10.1128/CMR.00116-14
    [69] Chavda KD, Chen L, Jacobs MR, et al. (2016) Molecular Diversity and Plasmid Analysis of KPC-Producing Escherichia coli. Antimicrob Agents Chemother 60: 4073-4081. https://doi.org/10.1128/AAC.00452-16
    [70] Bitar I, Caltagirone M, Villa L, et al. Interplay among IncA and blaKPC-Carrying Plasmids in Citrobacter freundii. Antimicrob Agents Chemother (2019)63: e02609-18. https://doi.org/10.1128/AAC.02609-18
    [71] Hancock SJ, Phan MD, Peters KM, et al. (2017) Identification of IncA/C Plasmid Replication and Maintenance Genes and Development of a Plasmid Multilocus Sequence Typing Scheme. Antimicrob Agents Chemother 61: e01740-16. https://doi.org/10.1128/AAC.01740-16
    [72] Wailan AM, Paterson DL, Kennedy K, et al. (2016) Genomic Characteristics of NDM-producing Enterobacteriaceae isolates in Australia and their blaNDM genetic contexts. Antimicrob Agents Chemother 60: 136-141. https://doi.org/10.1128/AAC.01243-15
    [73] Brehony C, McGrath E, Brennan W, et al. (2019) An MLST approach to support tracking of plasmids carrying OXA-48-like carbapenemase. J Antimicrob Chemother 74: 1856-1862. https://doi.org/10.1093/jac/dkz136
    [74] Matsumura Y, Peirano G, Bradford PA, et al. (2018) Genomic characterization of IMP and VIM carbapenemase-encoding transferable plasmids of Enterobacteriaceae. J Antimicrob Chemother 73: 3034-3038. https://doi.org/10.1093/jac/dky303
    [75] Peirano G, Chen L, Kreiswirth BN, et al. (2020) Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147. Antimicrob Agents Chemother 64. https://doi.org/10.1128/AAC.01148-20
    [76] Kochan TJ, Nozick SH, Medernach RL, et al. (2022) Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates. BMC Infect Dis 22: 603. https://doi.org/10.1186/s12879-022-07558-1
    [77] Logan LK, Weinstein RA (2017) The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis 215: 28-36. https://doi.org/10.1093/infdis/jiw282
    [78] Shafiq M, Zeng M, Permana B, et al. (2022) Coexistence of blaNDM–5 and tet(X4) in international high-risk Escherichia coli clone ST648 of human origin in China. Front Microbiol 13: 1031688. https://doi.org/10.3389/fmicb.2022.1031688
    [79] Haeili M, Barmudeh S, Omran M, et al. (2023) Whole-genome sequence analysis of clinically isolated carbapenem resistant Escherichia coli from Iran. BMC Microbiol 23. https://doi.org/10.1186/s12866-023-02796-y
    [80] Farzana R, Jones LS, Rahman MA, et al. (2023) Genomic Insights Into the Mechanism of Carbapenem Resistance Dissemination in Enterobacterales From a Tertiary Public Heath Setting in South Asia. Clin Infect Dis 76: 119-133. https://doi.org/10.1093/cid/ciac287
    [81] Quinteira S, Luisa-Peixe HF (2005) First isolation of blaVIM-2 in an environmental isolate of Pseudomonas pseudoalcaligenes. Antimicrob Agents Chemother 49: 2140-2141. https://doi.org/10.1128/AAC.49.5.2140-2141.2005
    [82] Muniesa M, Garcia A, Miro E, et al. (2004) Bacteriophages and diffusion of β-lactamase genes. Emerging Infect Dis 10: 1134-1137. https://doi.org/10.3201/eid1006.030472
    [83] Tiedje JM, Fang W, Manaia CM, et al. (2019) Antibiotic resistance genes in the human-impacted environment: a One Health perspective. Pedosphere 23: 273-282. https://doi.org/10.1016/S1002-0160(18)60062-1
    [84] Cantón R, Ruiz-Garbajosa P (2011) Co-resistance: An opportunity for the bacteria and resistance genes. Curr Opin Pharmacol 11: 477. https://doi.org/10.1016/j.coph.2011.07.007
    [85] Borer A, Saidel-Odes L, Riesenberg K, et al. (2009) Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteraemia. Infect Control Hosp Epidemiol 30: 972. https://doi.org/10.1086/605922
    [86] Cantón R, Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9: 466-475. https://doi.org/10.1016/j.mib.2006.08.011
    [87] Nordmann P, Picazo JJ, Mutters R, et al. (2011) Comparative activity of carbapenem testing: The COMPACT study. J Antimicrob Chemother 66: 1070-1078. https://doi.org/10.1093/jac/dkr056
    [88] Cantón R, Novais A, Valverde A, et al. (2008) Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clini Microbiol Infect 144–153. https://doi.org/10.1111/j.1469-0691.2007.01850.x
    [89] Walsh TR, Weeks J, Livermore DM, et al. (2011) Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: An environmental point prevalence study. Lancet Infect Dis 11: 355-362. https://doi.org/10.1016/S1473-3099(11)70059-7
    [90] Bushnell G, Mitrani-Gold F, Mundy LM (2013) Emergence of New Delhi metallo-β-lactamase type 1-producing Enterobacteriaceae and Non-Enterobacteriaceae: Global case detection and bacterial surveillance. Int J Infect Dis 17: 325-333. https://doi.org/10.1016/j.ijid.2012.11.025
    [91] Dadashi M, Yaslianifard S, Hajikhani B, et al. (2019) Frequency distribution, genotypes and prevalent sequence types of New Delhi metallo-β-lactamase-producing Escherichia coli among clinical isolates around the world: A review. J Global Antimicrob Resist 19: 284-293. https://doi.org/10.1016/j.jgar.2019.06.008
    [92] Brink AJ, Coetzee J, Clay CG, et al. (2012) The spread of carbapenem-resistant Enterobacteriaceae in South Africa: Risk factors for acquisition and prevention. S Afr Med J 102: 599-601. https://doi.org/10.7196/SAMJ.5789
    [93] Andriamanantena TS, Ratsima E, Rakotonirina HC, et al. (2010) Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar. Ann Clinical Microbiol Antimicrob 9: 17. https://doi.org/10.1186/1476-0711-9-17
    [94] Baraka K, Abozahra R, Haggag MM, et al. (2023) Genotyping and molecular investigation of plasmid-mediated carbapenem resistant clinical Klebsiella pneumoniae isolates in Egypt. AIMS Microbiol 9: 228-244. https://doi.org/10.3934/microbiol.2023014
    [95] Poirel L, Ros A, Carrer A, et al. (2011) Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J Antimicrob Chemother 66: 1181. https://doi.org/10.1093/jac/dkr023
    [96] Donald HM, Scaife W, Amyes SG, et al. (2000) Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother 44: 196-199. https://doi.org/10.1128/AAC.44.1.196-199.2000
    [97] Singh-Moodley A, Perovic O (2016) Antimicrobial susceptibility testing in predicting the presence of carbapenemase genes in Enterobacteriaceae in South Africa. BMC Infect Dis 16: 536. https://doi.org/10.1186/s12879-016-1858-7
    [98] Swe-Han KS, Pillay M, Schnugh D, et al. (2017) Horizontal transfer of OXA-23-carbapenemase-producing Acinetobacter species in intensive care units at an Academic Complex Hospital, Durban, KwaZulu-Natal, South Africa. S Afr J Infect Dis 32: 119-126. https://doi.org/10.4102/sajid.v32i4.36
    [99] Okeke NO, Laxminarayan R, Bhutta ZA, et al. (2005) Antimicrobial resistance in developing countries. Part I: Recent trends and current status. Lancet Infect Dis 5: 481-493. https://doi.org/10.1016/S1473-3099(05)70189-4
    [100] Moyane JN, Jideani AIO, Aiyegoro OA (2013) Antibiotics usage in food-producing animals in South Africa and impact on humans: Antibiotic resistance. Afr J Microbiol Res 7: 2990-2997. https://doi.org/10.5897/AJMR2013.5631
    [101] Montso KP, Dlamini SB, Kumar A, et al. (2019) Antimicrobial resistance factors of extended-spectrum beta-lactamases producing and isolated from cattle farms and raw beef in North-West province, South Africa. BioMed Res Int 4318306. https://doi.org/10.1155/2019/4318306
    [102] Jaja IF, Oguttu JW, Iwu CJ, et al. (2020) Prevalence and distribution of antimicrobial resistance determinants of Escherichia coli isolates obtained from meat in South Africa. PLoS ONE 15. https://doi.org/10.1371/journal.pone.0216914
    [103] Meissner HH, Scholtz MM, Palmer AR (2013) Sustainability of the South African livestock sector towards 2050. Part 1: Worth and impact of the sector. S Afr J Anim Sci 43: 282-297. https://doi.org/10.4314/sajas.v43i3
    [104] Landers TF, Cohen B, Wittum TE, et al. (2012) A review of antibiotic use in food animals: Perspective, policy, and potential. Public Health Rep 127: 4-22. https://doi.org/10.1177/003335491212700103
    [105] Henton MM, Eagar HA, Swan GE, et al. (2011) Antibiotic management and resistance in livestock production. S Afr Med J 101: 1-7.
    [106] (2014) WHOAntimicrobial resistance: 2014 global report on surveillance. Geneva: World Health Organization.
    [107] Pauly N, Klaar Y, Skladnikiewicz-Ziemer T, et al. (2021) Isolation procedure for CP E. coli from caeca samples under review towards an increased sensitivity. Microorganisms 9: 1105. https://doi.org/10.3390/microorganisms9051105
    [108] Marshall BM, Levy SB (2011) Food animals and antimicrobials: Impacts on human health. Clin Microbiol Rev 24: 718-733. https://doi.org/10.1128/CMR.00002-11
    [109] Phillips I, Casewell M, Cox T, et al. (2004) Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J Antimicrob Chemother 53: 28-52. https://doi.org/10.1093/jac/dkg483
    [110] Morrison BJ, Rubin JE (2015) Carbapenemase producing bacteria in the food supply escaping detection. PLoS One 10: e0126717. https://doi.org/10.1371/journal.pone.0126717
    [111] Fischer J, Rodríguez I, Schmoger S, et al. (2012) Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. J Antimicrob Chemother 67: 1793-1795. https://doi.org/10.1093/jac/dks108
    [112] Koluman A, Dikici A (2013) Antimicrobial resistance of emerging foodborne pathogens: Status quo and global trends. Crit Rev Microbiol 39: 57-69. https://doi.org/10.3109/1040841X.2012.691458
    [113] Roschanski N, Guenther S, Vu TTT, et al. (2017) VIM-1-producing Escherichia coli isolated from retail seafood, Germany 2016. Euro Surveillance 22: 17-00032. https://doi.org/10.2807/1560-7917.ES.2017.22.43.17-00032
    [114] Malande OO, Du Plessis A, Rip D, et al. (2016) Invasive carbapenem-resistant Enterobacteriaceae infection at a paediatric hospital: A case series. S Afr Med 106: 877. https://doi.org/10.7196/SAMJ.2016.v106i9.11028
    [115] Fischer J, San JM, Roschanski N, et al. (2017) Spread and persistence of VIM-1 carbapenemase-producing Enterobacteriaceae in three German swine farms in 2011 and 2012. Vet Microbiol 200: 118-123. https://doi.org/10.1016/j.vetmic.2016.04.026
    [116] Naas T, Bentchouala C, Cuzon G, et al. (2011) Outbreak of Salmonella enterica serotype infantis producing ArmA 16S RNA methylase and CTX-M-15 extended-spectrum β-lactamase in a neonatology ward in Constantine, Algeria. Int J Antimicrob Agents 38: 135-9. https://doi.org/10.1016/j.ijantimicag.2011.04.012
    [117] Falgenhauer L, Ghosh H, Guerra B, et al. (2017) Comparative genome analysis of IncHI2 VIM-1 carbapenemase-encoding plasmids of Escherichia coli and Salmonella enterica isolated from a livestock farm in Germany. Vet Microbiol 200: 114-117. https://doi.org/10.1016/j.vetmic.2015.09.001
    [118] Gullberg E, Albrecht LM, Karlsson C, et al. (2014) Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals. Am Soc Microbiol 5: e01918-14. https://doi.org/10.1128/mBio.01918-14
    [119] Pulss S, Semmler T, Prenger-Berninghoff E, et al. (2017) First report of an Escherichia coli strain from swine carrying and OXA-181 carbapenemase and the colistin determinant MCR-1. International J Antimicrob Agents 50: 232-236. https://doi.org/10.1016/j.ijantimicag.2017.03.014
    [120] Zhang WJ, Lu Z, Schwarz S, et al. (2013) Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin. J Antimicrob Chemother 68: 1681-1682. https://doi.org/10.1093/jac/dkt066
    [121] Wang Y, Wu C, Zhang Q, et al. (2012) Identification of New Delhi metallo-β-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One 7: 37152. https://doi.org/10.1371/journal.pone.0037152
    [122] Shen Y, Hu F, Wang Y, et al. (2022) Transmission of Carbapenem Resistance Between Human and Animal NDM-Positive Escherichia coli Strains. Engineering 15: 24-33. https://doi.org/10.1016/j.eng.2021.07.030
    [123] Pruthvishree BS, Vinodh-Kumar OR, Sinha DK, et al. (2017) Spatial molecular epidemiology of carbapenem-resistant and New Delhi metallo beta-lactamase (blaNDM)-producing Escherichia coli in the piglets of organized farms in India. J Appl Microbiol 122: 1537-1546. https://doi.org/10.1111/jam.13455
    [124] Poirel L, Walsh TR, Cuvilliera V, et al. (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70: 119-123. https://doi.org/10.1016/j.diagmicrobio.2010.12.002
    [125] Antunes LS, Visca P, Towner KJ (2014) Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis 71: 292-301. https://doi.org/10.1111/2049-632X.12125
    [126] Klotz P, Göttig S, Leidner U, et al. (2017) Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates. PLoS One 12. https://doi.org/10.1371/journal.pone.0171986
    [127] Webb HE, Bugarel M, den Bakker HC, et al. (2016) Carbapenem-resistant bacteria recovered from faeces of dairy cattle in the high plains region of the USA. PLoS One 11. https://doi.org/10.1371/journal.pone.0147363
    [128] EFSA & ECDC.European Food Safety Authority: The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016. Eur Food Saf Authority J (2018) 16: 5182. https://doi.org/10.2903/j.efsa.2018.5182
    [129] Hamza E, Dorghan SM, Hamza DA (2016) Carbapenemase-producing Klebsiella pneumoniae in broiler poultry farming in Egypt. J Global Antimicrob Resist 7: 8-10. https://doi.org/10.1016/j.jgar.2016.06.004
    [130] Brahmi S, Touati A, Cadière A, et al. (2016) First description of two sequence type 2 Acinetobacter baumannii isolates carrying OXA-23 carbapenemase in Pagellus acarne. Antimicrob Agents Chemother 60: 2513-2515. https://doi.org/10.1128/AAC.02384-15
    [131] Essack SY, Bester L (2010) Antibiotic resistance via the food chain: Fact or fiction?. S Afr J Sci 106: 1-5. https://doi.org/10.4102/sajs.v106i9/10.281
    [132] Kjeldgaard J, Cohn MT, Casey PG, et al. (2012) Residual antibiotics disrupt meat fermentation and increase risk of infection. Am Soc Microbiol 3: 1-4. https://doi.org/10.1128/mBio.00190-12
    [133] Doyle MP, Loneragan GH, Scott HM, et al. (2013) Antimicrobial resistance: Challenges and perspectives. Compr Rev Food Sci Food Saf 12: 234-248. https://doi.org/10.1111/1541-4337.12008
  • This article has been cited by:

    1. Kalyan Manna, Vitaly Volpert, Malay Banerjee, Pattern Formation in a Three-Species Cyclic Competition Model, 2021, 83, 0092-8240, 10.1007/s11538-021-00886-4
    2. Min Lu, Chuang Xiang, Jicai Huang, Hao Wang, Bifurcations in the diffusive Bazykin model, 2022, 323, 00220396, 280, 10.1016/j.jde.2022.03.039
    3. Glenn Webb, Xinyue Evelyn Zhao, Bifurcation analysis of critical values for wound closure outcomes in wound healing experiments, 2023, 86, 0303-6812, 10.1007/s00285-023-01896-7
    4. Mengxin Chen, Pattern dynamics of a Lotka-Volterra model with taxis mechanism, 2025, 484, 00963003, 129017, 10.1016/j.amc.2024.129017
    5. Swadesh Pal, Roderick Melnik, Nonlocal Models in Biology and Life Sciences: Sources, Developments, and Applications, 2025, 15710645, 10.1016/j.plrev.2025.02.005
    6. Kalyan Manna, Swadesh Pal, Malay Banerjee, Effects of spatiotemporal, temporal and spatial nonlocal prey competitions on population distributions for a prey-predator system with generalist predation, 2025, 0, 1531-3492, 0, 10.3934/dcdsb.2025106
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2412) PDF downloads(205) Cited by(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog